Please ENTER to search

← Back

Active Pharmaceutical Ingredients

High-quality APIs for pharmaceutical applications

Innovative Solutions and Trusted Expertise in API Manufacturing

Welcome to the core of API manufacturing. At SCL Lifesciences, we are proud to be your trusted partner as a CDMO/CMO in the domain of API manufacturing. In the complex world of pharmaceuticals, the journey can be challenging. That's why we are committed to simplifying this journey by providing high quality APIs, specialty and performance chemicals, and advanced intermediates. Our offerings include high-potent molecules to niche generics like Homatropine, Dexketoprofen, Atropine, and papaverine etc., backed by high compliance certifications.

As a leading API manufacturer, we understand the importance of reliable, time-bound delivery. We focus on customer service, flexibility, and delivering solutions that not only meet immediate needs but also ensure long-term success for our partner organization.

From raw material procurement, chemical synthesis, isolation, and purification, to QC and packaging, we offer unwavering commitment to quality and safety. Our unique value proposition lies in our strong backward integration, allowing us to manufacture key raw materials essential to our products. This ensures a seamless supply chain, guaranteeing superior quality and cost efficiency.

Our commercial APIs are distributed globally, from Europe, the United States to Japan, Korea, Brazil, Turkey, Russia, and CIS countries, as well as South & Central America, the Middle East, and North Africa. At our state-of-the-art Knowledge Centre in Hyderabad, we support critical stages of development and optimization, ensuring you can move forward confidently through each phase of development and market introduction.

Our APIs

View our complete API list to find the right solution for your pharmaceutical needs.

COMMERCIAL APIs

APIs BEING LAUNCHED

Bempedoic acid

Therapeutic Area: Lipid Lowering Agent

Expected: Q3 2025

Dapagliflozin

Therapeutic Area: Type-II Antidiabetic

Expected: Q2 2025

Daprodustat

Therapeutic Area: Treatment of Anaemia due to CKD

Expected: Q3 2025

Empagliflozin

Therapeutic Area: Antidiabetic

Expected: Q4 2025

Ketoprofen Lysinate

Therapeutic Area: Non-Steroidal Anti-Inflammatory Drug, or NSAID

Expected: Q3 2025

Ticagrelor

Therapeutic Area: Antiplatelet

Expected: Q3 2025

Tribenoside

Therapeutic Area: Anti-inflammatory, analgesic, and wound healing properties

Expected: Q4 2025

API's UNDER DEVELOPMENT

Edoxaban Tosylate

Therapeutic Area: Direct oral anticoagulants (DOACs)

Expected: Q1 2026

Isavuconazonium Sulfate

Therapeutic Area: Azole antifungals

Expected: Q2 2026

Ozanimod

Therapeutic Area: Treatment of relapsing multiple sclerosis and ulcerative colitis

Expected: Q4 2025

Tafamidis Meglumine

Therapeutic Area: Transthyretin kinetic stabilizer

Expected: Q1 2026

Upadacitinib Hemihydrate

Therapeutic Area: Janus kinase (JAK)1-selective inhibitor

Expected: Q1 2026

Vonoprazan

Therapeutic Area: Potassium-competitive acid blockers (PCAB)

Expected: Q1 2026

Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. The liability of any sale into such protected markets is at buyer's risk.

Here's why we stand out as your ideal partner

Discover why we are your ideal partner, delivering unmatched expertise, reliability, and innovative solutions.

Certified API
Certified API Manufacturing Facilities
Raw Production
Backward Integrated in-house production of KSM
cGMP Compliance
High-Potency API (HPAPI) Manufacturing with cGMP Compliance
Global Reach
Extensive Global Reach with Exports to 80+ Countries
Specialized API Production
Specialized Production Icon

Specialized API Production Capabilities at SCL Lifesciences

Among API manufacturing companies, we stand out for our commitment to innovation and reliability. If you are looking for an active pharmaceutical ingredient manufacturer then, our expertise ensures your success.

Specialized API Production
Specialized Production Icon
  • Accredited by global regulatory bodies such as the WHO Geneva, US FDA, Japanese PMDA and EDQM, our facilities maintain the highest standards of API manufacturing synthesis, safety, and sustainability. Our regular production is supplemented by one of the country's largest capacity for high pressure reactions.
  • As an experienced API pharma company, our Small Volume Facility features a KG Scale & Pilot Facility with equipment ranging from 63 L to 1000 L, designed specifically for low-volume and high-value APIs.
  • This specialized facility adheres to cGMP standards and supports high-potency API (HPAPI) production, ensuring precise and secure manufacturing processes.
  • As a well-established active pharmaceutical ingredients manufacturer, our facility is frequently used for regulatory filings with authorities like the USFDA, PMDA, and EDQM, reflecting our strong focus on compliance and quality.
  • Our API site is supplemented by an Intermediate manufacturing site specialized in Bromine Chemistry, capable of handling 3- 3.5 MT of Bromine daily.

Questions you may have?

Find answers to the most commonly asked questions about our services.

An API, or Active Pharmaceutical Ingredient, is the therapeutically active component in a pharmaceutical drug that produces the intended therapeutic effect. It is the key ingredient that makes the medicine work. At SCL Lifesciences, we specialize in manufacturing high-quality APIs that meet global regulatory standards.

Currently, SCL Lifesciences offers a wide range of APIs that cater to a wide range of therapeutic areas, including Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Cardiovascular System (CVS), Anti-Diabetic, Anti-cholinergic, Central Nervous System (CNS), Anti-filarial, Anthelmintics and more.

Partnering with SCL Lifesciences means access to certified API manufacturing facilities, continuous supply with in-house raw material production, and cGMP-compliant high-potency API (HPAPI) manufacturing. With a strong global presence in 80+ countries, we ensure reliability, quality, and regulatory excellence for your API needs.

Accredited by global regulatory bodies such as WHO-Geneva, US FDA, Japanese PMDA, Korean MFDS, and EDQM etc., our facilities uphold the highest standards in API synthesis, safety, and sustainability. In addition to regular production, we house one of the country's largest capacities for high-pressure reactions, ensuring efficiency and scalability.

Reference of the compliance list:

  • WHO Geneva Empanelment
  • Japanese Pharmaceutical and Medical Devices Agency (JPMDA)
  • United States Food and Drug Administration (USFDA)
  • Ministry of Food and Drug Safety (MFDS) Korea
  • European Directorate for the Quality of Medicines & HealthCare (EDQM)
  • Therapeutic Goods Administration (TGA) Australia

Absolutely. SCL Lifesciences provides DMFs in CTD format as and when required, stability data, microbiology studies, analytical data support, GMP certifications to support customer filings.

Yes, SCL Lifesciences offers customized API solutions tailored to meet specific customer requirements. Our expertise in process development, scale-up, and regulatory compliance enables us to provide high-quality, cost-effective, and scalable solutions. Whether you need modifications to existing APIs or the development of new molecules, our experienced R&D and manufacturing teams ensure optimal results while adhering to global regulatory standards.
dots

Explore our related services

Browse through our related services that complement your needs and provide comprehensive solutions.

Footer Form Banner

Ready to discuss your needs with us?

Request you to provide all details mentioned in the form along with your business requirement. It will help us route your query to the appropriate person.

Please enter a valid name (only alphabets and spaces allowed).
Please enter your organization name.
Please enter a valid work email address.
Please enter a valid phone number.
Please select your country.
Please enter your message.
You must agree to the privacy policy.